Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Experimental Aging Research|May 31, 2003
Age-associated increases in intensity discrimination for tasteSteven Nordin, L Jill Razani, Stacy Markison, et al.Idrugs : the Investigational Drugs Journal|April 1, 2005
MC4 receptor antagonists: a potential treatment for cachexiaAlan C Foster, Chen Chen, Stacy Markison, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 17, 2004
Central structures necessary and sufficient for ingestive and glycemic responses to Urocortin I administrationDerek Daniels, Stacy Markison, Harvey J Grill, et al.Toxicology Reports|October 1, 2017
Toxicological evaluation of a novel cooling compound: 2-(4-methylphenoxy)-<i>N</i>-(1<i>H</i>-pyrazol-3-yl)-<i>N</i>-(2-thienylmethyl)acetamideDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.Toxicology Reports|October 1, 2017
Toxicological evaluation of the flavour ingredient 4-amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acidAmy J Arthur, Donald S Karanewsky, Hanghui Liu, et al.Toxicology Reports|September 30, 2017
Toxicological evaluation of a novel umami flavour compound: 2-(((3-(2,3-Dimethoxyphenyl)-1<i>H</i>-1,2,4-triazol-5-yl)thio)methyl)pyridineDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.Toxicology Reports|September 30, 2017
Toxicological evaluation of two novel bitter modifying flavour compounds: 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)imidazolidine-2,4-dione and 3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1<i>H</i>-pyrazol-4-yl)-1-(3-hydroxybenzyl)-5,5-dimethylimidazolidine-2,4-dioneDonald S Karanewsky, Amy J Arthur, Hanghui Liu, et al.Pituitary|January 9, 2022
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteersAjay Madan, Stacy Markison, Stephen F Betz, et al.Journal of the American Society of Nephrology : JASN|August 10, 2007
Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in miceWai W Cheung, Huey-Ju Kuo, Stacy Markison, et al.Biochemistry|November 3, 2005
Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptorBeth A Fleck, Chen Chen, Weidong Yang, et al.Pageof 4